That’s the conclusion of hiring managers at four of the state’s leading life sciences companies who spoke at a recent career ...
Trump's threat of imposing a tariff on Denmark over desires to acquire Greenland has caught the attention of one of the ...
There is no sign of a slowdown in Johnston County's rapid growth, meaning things like cost of living and infrastructure are ...
Novo Nordisk is conducting a different study to understand how and why semgalutide seems to reduce the progression of kidney disease, said Stephen Gough, global chief medical officer and senior ...
North Carolina achieved a record-breaking year for life sciences investments in 2024. Twenty-five companies announced ...
The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, expanding the use of the wildly popular injection in the U.S. The FDA ...
The Danish drug giant Novo Nordisk, known for its antidiabetes and weight loss drugs such as semaglutide (Ozempic or Wegovy), has been censured by the UK’s Prescription Medicines Code of Practice ...
Kaitlin McKeown [email protected] Caleb Wixted, Harris Travis and Sam Wixted sled down a hill in Durham, N.C. on Wednesday, Jan. 22, 2025. Kaitlin McKeown [email protected] A ...
DURHAM, N.C., Jan. 22 ... today announced a strategic collaboration and license agreement with Novo Nordisk A/S to co-develop oral therapies for sickle cell disease (SCD) and other chronic ...
A new study found that patients taking GLP-1s to treat type 2 diabetes have a lower risk of developing Alzheimer’s disease, potentially opening the door … ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback